Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor [6]

Diabetes Care

Volumn 21, Issue 4, 1998, Pages 672-673

  Hayashi, R ^a   Hayakawa, N ^a   Makino, M ^a   Nagata, M ^a   Kakizawa, H ^a   Uchimura, K ^a   Hamada, M ^a   Aono, T ^a   Fujita, T ^a   Shinohara, R ^a   Nagasaka, A ^a   Itoh, M ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; EPALRESTAT; SORBITOL;

ADOLESCENT; ADULT; AGED; ASSAY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ERYTHROCYTE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCHOOL CHILD; SPECTROPHOTOMETRY;

ADOLESCENT; ADULT; AGED; ALDEHYDE REDUCTASE; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; ENZYME INHIBITORS; ERYTHROCYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RHODANINE; SORBITOL; SPECTROPHOTOMETRY; THIAZOLIDINES;

EID: 0031898391     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.4.672     Document Type: Letter

References (17)